Complement activation and cryoglobulinemia are common in monoclonal gammopathy of renal significance: Data from a case series

被引:0
|
作者
Skoberne, Andrej [1 ,3 ]
Skerget, Matevz [2 ,3 ]
Kojc, Nika [4 ]
Frelih, Maja [4 ]
Rigler, Andreja Ales [1 ,3 ]
Haler, Zeljka Veceric [1 ,3 ]
Borstnar, Spela [1 ,3 ]
Rotar, Nusa Avgustin [1 ,3 ]
Kova, Damjan [1 ,3 ]
Lindi, Jelka [1 ,3 ]
Zver, Samo [2 ,3 ]
机构
[1] Univ Med Ctr Ljubljana, Dept Nephrol, Zaloska Cesta 7, Ljubljana 1000, Slovenia
[2] Univ Med Ctr Ljubljana, Dept Hematol, Ljubljana, Slovenia
[3] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[4] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia
关键词
anti-factor H autoantibody; C5b-9; cryoglobulins; proliferative glomerulonephritis with monoclonal immunoglobulin; deposits; eculizumab; GLOMERULONEPHRITIS;
D O I
10.5414/CNP96S03
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Monoclonal gammopathy of renal significance (MGRS) denotes kidney diseases caused by monoclonal immunoglobulins in patients who do not have an overt hematological malignancy. Treatment is primarily directed against the underlying clone. Complement activation and cryoglobulinemia are known factors that can contribute to tissue damage, however, the full extent of their involvement is not clear. Materials and methods: This was a retrospective study including all patients with MGRS referred for consultation to our hospital over a 3-year period. Results: We identified 17 patients, of which 12 had proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID). Treatment with anti-clonal or immunosuppressive therapy was successful in 60% of patients with PGNMID, and treatment success was more common in patients with lambda chain (100%) compared to kappa chain deposits (20%). Serum markers of complement involvement were identified in 41% of all patients (88% of tested samples), most commonly high serum C5b-9 values or anti-factor H autoantibodies (both 24%). Patients with complement involvement did not respond well to treatment, which was unsuccessful in all treated patients with anti-factor H autoantibodies and 75% of patients with high serum C5b-9 values. Cryoglobulinemia was identified in 29% of all patients (71% tested samples) and was monoclonal in 40% of positive cases and mixed in 60%. None of the patients with cryoglobulinemia had organized deposits, however, there was a trend toward more common intramembranous deposits. In patients with monoclonal cryoglobulinemia both anti-clonal and immunosuppressive treatment were unsuccessful. All patients with mixed cryoglobulinemia were treated successfully with immunosuppressive therapy. Conclusion: Treatment of patients with PGNMID was successful in most cases. Complement involvement as well as monoclonal and mixed cryoglobulinemia were relatively common in our cohort, with the first two generally associated with unsuccessful treatment and the latter with successful treatment.
引用
收藏
页码:S16 / S23
页数:8
相关论文
共 50 条
  • [31] Autologous Stem Cell Transplantation As a Treatment Modality for Type 1 Cryoglobulinemia in Monoclonal Gammopathy of Renal Significance
    Wang, Zhen
    Biran, Noa
    Skarbnik, Alan P.
    Pecora, Andrew L.
    Donato, Michele L.
    Rowley, Scott D.
    Siegel, David S.
    Vesole, David H.
    Richter, Joshua R.
    BLOOD, 2016, 128 (22)
  • [32] A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19
    Gonzalez-Lugo, Jesus D.
    Bachier-Rodriguez, Lizamarie
    Goldfinger, Mendel
    Shastri, Aditi
    Sica, R. Alejandro
    Gritsman, Kira
    Mehta, Vikas
    Kabarriti, Rafi
    Goel, Sanjay
    Verma, Amit
    Braunschweig, Ira
    Kornblum, Noah
    Mantzaris, Ioannis
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (03) : E130 - E133
  • [33] Abnormal coagulation profiles in monoclonal gammopathy of undetermined significance: a case series
    McCaughan, Georgia
    Jarvis, Susan
    Joseph, Joanne
    PATHOLOGY, 2021, 53 (06) : 798 - 800
  • [34] Post-Transplant Monoclonal Gammopathy of Renal Significance: A Case Report
    Echeverri, Carolina Movilla
    Cosano, Gema Montilla
    Garrido, Carlos Rivera
    Poblet, Marta Suner
    Benjumea, Alejandro Suarez
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (10) : 2301 - 2303
  • [35] Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China
    Yu, Xiao-Juan
    Zhang, Xin
    Li, N-Yang
    Wang, Su-Xia
    Zhou, Fu-De
    Zhao, Ming-Hui
    NEPHROLOGY, 2020, 25 (03) : 202 - 211
  • [36] An update to the pathogenesis for monoclonal gammopathy of renal significance
    Zuo, Chao
    Zhu, Yuge
    Xu, Gaosi
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 149
  • [37] Monoclonal gammopathy of renal significance (MGRS). An overview
    Hegenbart, Ute
    Beimler, Joerg
    Schoenland, Stefan
    NEPHROLOGIE, 2024, 19 (05): : 294 - 300
  • [38] An update to the pathogenesis for monoclonal gammopathy of renal significance
    Chao Zuo
    Yuge Zhu
    Gaosi Xu
    Annals of Hematology, 2020, 99 : 703 - 714
  • [39] An update to the pathogenesis for monoclonal gammopathy of renal significance
    Zuo, Chao
    Zhu, Yuge
    Xu, Gaosi
    ANNALS OF HEMATOLOGY, 2020, 99 (04) : 703 - 714
  • [40] Monoclonal Gammopathy of Renal Significance: Not Reserved for the Elderly
    Balakrishnan, Suryanarayanan
    Martin, Suzanne G.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 590 - 590